HPVdetectioninoralcarcinomas
DetecçãodoHPVemcarcinomasorais
AuroraKarladeLacerdaVidal1;ArnaldodeFrançaCaldasJúnior2;RobertoJoséVieiradeMello3; VirgíniaRibesA.Brandão4;GetúlioIsidorodaRocha5;ElianeTaromaru6
y
key words
abstract
Theauthorssetoutinthisstudytoverifythepresenceoflow-andhigh-riskDNAofhumanpapilloma-virus(HPV)inoralcancerbymeansofthehybridcaptureDigene®test(SãoPaulo-SP,Brazil)insmears
fromexfoliativecytologyandalsotocomparethefindingswiththoseofconventionallightmicroscopy (hematoxylin-eosin(HE)/Papanicolaou).Fortyindividualsgavetheirwritteninformedconsenttoparti-cipateinthestudyandalsohadtheirclinicaldataanalyzed.The40exfoliativecytologyexaminations performedtodateproducedthefollowingresults:29(72.5%)negativeforlow-andhigh-riskHPV-DNA; nine(22.5%)positiveforlow-andhigh-riskHPV-DNA;one(2.5%)positiveforlow-riskHPV-DNA;and one(2.5%)positiveforhigh-riskHPV-DNA.Therewasagreementamongthefindingsforthepresence
ofDNA-HPVforbothexfoliativecytology(smeartohybridcaptureDigene®testandthecytological
smearreadingsmadebyconventionallightmicroscopy).ItwasthereforeconcludedthattheHPVvirus maybeacocarcinogenofthemouthcancerasitisinthecervixcancer.
Oralcancer
HPV
Exfoliativecytology
Hybridcapture
resumo
Osautoresbuscaramverificar,nesteestudo,apresençadopapilomavírushumano(HPV)debaixoedealto riscoemcarcinomasoraisatravésdotestedecapturahíbridaDigene®(SãoPaulo-SP,Brasil)emamostrascolhidaspelacitologiaesfoliativabucale,ainda,avaliarcomparativamenteasreferidasleiturascomalterações celularesindicativasdestevírusobtidascomainterpretaçãocitológicaópticaconvencional(hematoxilina-eosina(HE)/Papanicolaou).Quarentaindivíduosconcordaram,espontaneamente,atravésdeassinaturado termodeconsentimentolivreeesclarecido,emparticipardapesquisa,eseusdadosclínicosforamanalisados. Entreas40amostrasprovenientesdacitologiaesfoliativa29(72,5%)mostraram-senegativasparapresença deHPV-DNAdebaixoedealtorisco;nove(22,5%)forampositivasparaoHPV-DNAdebaixoedealtorisco; uma(2,5%)foipositivaapenasparaoHPVdebaixorisco;etambémuma(2,5%)foipositivaapenaspara oHPVdealtorisco.HouveconcordânciaentretodososresultadospositivosparapresençadeHPV-DNAnas amostrascitológicassubmetidasaotestedecapturahíbridaDigene®enaleituradeesfregaçocitológicoao
microscópioópticoconvencional.Destaforma,conclui-sequeovírusHPVpodecomportar-secomomaisum co-carcinógenoparaocâncerdeboca,àsemelhançadocarcinomauterino.
Cânceroral
HPV
Citologiaesfoliativa
Capturahíbrida
1.DepartmentofPathology,UniversidadedePernambuco(UPE). 2.DepartmentofPreventiveandSocialDentistry/UPE.
3.DepartmentofPathology,HospitaldoCâncerdePernambuco;DepartmentofPathology,UniversidadeFederaldePernambuco(UFPE). 4.DepartmentofPathologicAnatomy/UPE.
5.DepartmentofHeadandNeck,HospitaldoCâncerdePernambuco. 6.TechnicianofLaboratórioDigenedoBrasil,SãoPaulo.
unitermos
JBrasPatolMedLab•v.40•n.1•p.21-6•fevereiro2004 0RIGINALPAPER
Primeirasubmissãoem09/07/03
Últimasubmissãoem15/07/03
Aceitoparapublicaçãoem21/07/03
Introduction
Mouthcancerisamongthetenmostcommonforms ofcancerworldwide.Owingtothehighdeathrateforthis typeofneoplasm,itisoneofthepublichealthproblemsin Brazilwhoseindiceshaveremainedstableorevenincreased
insomeregionsofthecountryinthepast40years(14).
Takingintoconsiderationtheetiologyofmouthcancer, in which both endogenous and exogenous factors are involved,wesetout,inthepresentstudy,toidentifyand verifyitspossiblerelationshipwiththehumanpapilloma virus (HPV) in view of the influence of this virus in the
causationofcervicalcarcinomaoftheuterus(7,10,18,21).
Dhariwal, Cubie and Southam(5) have stated that
infections by HPV have been shown to be present in cancers of the mouth and also that the DNA of the Epstein-Barr virus (EBV) has likewise been isolated in thesetypesoflesions,butthereisnoevidenceoftheir directactionintheprocessofmaligntransformationof
buccalepithelialcells(2).Furthermore,Maoetal.(12)have
emphasizedthattheinactivationofthep53proteinis the most frequent genetic alteration found in human tumors, premalignant and malignant tumors of the buccalepithelium.
HPV is among the first viruses to be associated with neoplasmsinhumans.TheinitialevidencethatHPVcould causecancercamefromthestudyofepidermodysplasia verruciformis (EV), a rare disease characterized by multiplecutaneouslesionsandimmunitytodefectivecell
measurement(16).
In1974,Hausenetal.initiatedstudiesthatledtothe
discoveryofHPVincarcinomaofthecervix,andother researchersthroughouttheworldhavenowconfirmed
this association(5, 10, 15, 18). Malignancy in many other
urogenitalandorallocationshasnowalsobeenrelated
toHPV(3).
ForDhariwal,CubieandSoutham(5),thediagnosisof
buccalinfectionbyHPVshouldbebasedonacombination of the clinical features and the histopathological examinations.
Thus,thepresenceofHPVinoralcancersshouldbe investigated,foritpointstotheactionofthevirusasafactor intheproductionofcancerofthemouthinparallelwith geneticand/orotherpredisposingexternalfactorssuchas smokingandalcohol,hencetheimportanceofitsdetection asearlyaspossible.
Forthisreasoninthepresentstudytheaimistoverify thepresenceoflow-andhigh-riskHPVinoralcarcinomas
by means of the hybrid capture tube test Digene® in
samplescollectedbyoralexfoliativecytology,amethod
recognized by a number of authors(8, 19) as effective for
collecting material from the oral cavity. In addition, the otherpresentexternalfactorsthatmayalsopredisposeto thedevelopmentofthediseaseareevaluated.
Emphasisislaidontheimportanceofthisresearchas atoolinearlydiagnosis,therebybroadeningthegamutof preventiveresourcesforbuccallesionscausedbyHPV,a possibleprecursorofcancerofthemouth.
Material and methods
Thiswasacross-sectionalstudytoidentifyHPVinoral carcinomasbymeansofsamplesobtainedbyexfoliative cytology(cytobrush),carriedoutintheHeadandNeck Outpatient Clinic and the Department of Pathology of HospitaldoCâncerdePernambuco,theIntegratedCenter ofPathologicalAnatomyofHospitalUniversitárioOswaldo Cruz of Universidade de Pernambuco, and Laboratório DigenedoBrazil,inSãoPaulo.
The patients spontaneously attending Hospital do CâncerdePernambuco,withdiagnosticoforalcarcinoma, wereselectedforthestudy,thepurposeofwhichwasto identifythevirusintheselesions.
After freely signing their informed consent, 67 individuals comprised the initial sample. Of these, 14 failedtoreturntotheclinicingoodtimetoenableusto collecttheirmaterialandforwarditforanalysis,and13 hadtheircollectedmateriallostintheprocessofbeing transportedowingtodeficienciesintheconditioningof thematerial.
Thus the final sample consisted of 40 cytological specimens which were submitted to the hybrid capture
tubetestDigene®forthepurposesofthestudy,allofwhich
werefromoralcarcinomasofsquamouscellsbeforethe startofthetreatment.
Acomparativeassessmentwasmadeofthecytological conclusions indicative of a diagnosis of HPV in the conventional light microscope readings of the samples versus the accurate detection of the virus by hybrid captureinthecytologicalsamples.
Clinical/laboratory procedures: the initial step was thehistorytakingandthecompletionofaclinicalrecord card for the specific purpose of this study. This was followedbytheextra-andintrabuccalexaminationand exfoliativecytologyintheareaofthelesion(shavingoffthe superficiallayerofmucosa–cytobrush),followedbythe preparation of the smear on slides with a frosted edge, dulyidentifiedandconditionedinplastictubescontaining thefixative:absolutealcoholPAforsubsequentlaboratory processing(Papanicolaoustainingandhematoxylin/eosin). The slides were mounted at the integrated center of pathologicalanatomy(Ciap–Huoc/UPE)andsubmitted to conventional interpretation by light microscopy. Immediately after this initial exfoliative cytological collection a further, identical collection was made, in which the material still present in the bristles of the cytobrushwasconditionedinthespecialDigenekit(with DNA-preservingsolution)fordetectionofHPVandsentto SãoPaulo,whereeachlaboratoryphaseforhybridcapture wasperformed.
The hybrid capture tube test is an examination processedbythetechniqueofmolecularhybridization, a Digene technology that uses nonradioactive probes with amplification of the detection of the hybrids by chemoluminescence.Thematerialforanalysisisdenatured andreactswithaspecificgenicprobe,formingRNA/DNA hybridsthatarecapturedbyantibodiesliningthetube wall.Next,theimmobilizedhybridsreactwithantibodies specificforRNA/DNAconjugatedtoalkalinephosphatase formingastablesubstract,andthehybridsaredetected by ultrasensitive chemoluminescence. For the HPV the sensitivityonamicroplateis1pg/ml,equivalentto0.1
viruscopypercell(20).
The hybrid capture tube test (Digene® technology)
containsthegenicprobesof70%ofthetypesoflow-risk HPV – 6, 11, 42, 43, 44 –, and 99% of the oncogenic types–16,18,31,33,35,39,45,51,52,56,58,59, 68.AnegativeresultindicatestheabsenceofDNA-HPVin
thetypesstudied(6).
The hybrid capture tube test Digene® is a molecular
biology test for HPV approved by the FDA and by the
BrazilianMinistryofHealth(6).
Itemphasizesthatthereadingistotallycomputerized, thechemoluminometerbeingcontrolledbysoftwarethat analyzes the numbers received from the readings and performsallthevalidationcalculationsofthetest.Thetest usesthereadingsfromthecontrolsforthevalidationand calculationofthecutoff(RLU=relativelightunit/PCAor
PCB = positive control A and positive control B/cutoff obtainedbythemeanofthethreepositivecontrols).
The independent variables were age, gender, color, occupation,smoking,ethylism,thepresenceorabsence ofpartialremovabledentalprosthesesandthepresence orabsenceoftheHPVvirusinthematerialcollected;the dependentvariablewasthefrequencyofindividualswith oralcarcinomas.
Adescriptivestudywasmadeofthedataobtainedin thepresentresearch.
Results and discussion
Thefinalsamplewasmadeupof40cytologicalspecimens from40oralcarcinomaswhosediagnosesconfirmedthe presenceofwellandmoderatelydifferentiatedcarcinomas
ofsquamouscells(17).
There was a 100% parity in the sample, since the same40subjectsgavesamplesforexfoliativecytologyby conventionalcytologicaldiagnosisandexfoliativematerial forthehybridcapturetubetestfortheidentificationofHPV
usingDigene®technology.
Ofthe40(100%)subjectsmakingupthefinalsample, 25(62.5%)weremalesand15females(37.5%).Theoverall meanagewas45.2years.
Amongthemales,25(100%)weresmokers,ofwhom17 (68%)alsodrank;amongthefemalesnine(60%)smoked.
Thefindingscorroboratethoseoftheliterature(14)when
theyassociateexternalfactorssuchasexposuretothesun withthebuccallesionsobserved,mainlyonthelowerlip. For15(60%)ofthemenwereagriculturalworkersexposed tothesun,aswellassmokers,anddevelopedcarcinomas ofsquamouscellsonthelowerlipandonthelateraledge ofthetongue.
Of the 40 (100%) cytological samples analyzed for theidentificationofHPVbythehybridcapturetubetest,
Digene®technology,29(72.5%)provedtobenegativefor
thepresenceoflow-andhigh-riskHPV;nine(22.5%)were positiveforlow-andhigh-riskHPV;one(2.5%)waspositive onlyforlow-riskHPV;andonewaspositiveonlyforhigh-risk
HPV(Table1).Inaddition,thereadingofthecytological
smearsbyconventionallightmicroscopyalsosignaledthe presenceofkoilocytes,thatis,alterationsindicativeofthe
presenceofHPVin13ofthesesamples(Table2)(9).
Resultsofthehybridcapturetubetest,Digene®technology,foridentificationofHPVinoral
squamouscellcarcinomas:materialobtainedbyexfoliativecytology
Table1
Methodused
Absenceof
Presenceof
Presenceof
Presenceof
Total
forobtaining
DNA-HPV
DNA-HPV
DNA-HPV
DNA-HPV
n
(%)
sample
forthe
forgroupA
forgroupB
forgroupAandB
types
(low-risk)
(high-risk) (low-andhigh-risk)
studied
viruses
viruses
viruses
n
(%)
n
(%)
n
(%)
n
(%)
Exfoliativecytology 29(72.5) 1(2.5) 1(2.5) 9(22.5) 40(100)
Resultsofthereadingofthecytologicalsmearbyconventionallightmicroscopy,
foridentificationofHPVinoralsquamouscellcarcinomas
Table2
Methodusedfor
Absenceof
PresenceofDNA-HPVviruses
Total
obtainingsample
DNA-HPVviruses
(presenceofkoilocytes)
n
(%)
n
(%)
n
(%)
Exfoliativecytology 27(67.5) 13(32.5) 40(100)
AccordingtoJonesetal.(8),SugermanandSavage(19),
exfoliativecytology,whenwellperformed,isanefficient way of collecting material from the oral cavity. In fact, butthisistruenotonlyfordiagnosis:italsopermitsthe detectionofthelow-and/orhigh-riskDNA-HPVvirusin thesamples.
With regard to the 40 lesions studied that were diagnosed as being carcinomas of squamous cells, nine (22.5%) presented a conclusive positive result for the presence of low- and high-risk DNA-HPV; as for the topographiclocation,sixweresituatedonthelateraledge ofthetongue;threewereonthelowerlip;one(2.5%), whose finding was positive for low-risk DNA-HPV was situatedonthelateraledgeofthetongue;andone(2.5%) thatwaspositiveforhigh-riskDNA-HPVwaslocatedinthe regionoftheretromolartrigone.
Theidentificationofthevirusisimportant;however,
epidemiologicaldatabyLübbeetal.(11)indicatethatinfection
byhigh-riskHPVisnotinitselfenoughforthedevelopment ofcancer.Itisknownthatthereare,infact,manyother
factors,e.g.smoking,ethylism,radiation,involvedinthe
developmentofthisneoplasmthatareinvariablypresent inpersonssufferingfromcancerofthemouth,asshown bythefindingsofthepresentstudyandthoseofmany
others(14).TheauthorsbelievethatthepresenceoftheHPV
virusmayalsocontributetothedevelopmentofthisdisease onthebasisofreasonsanalogoustothatofitsactionin cervicovaginalepithelium.
Epidemiologicaldataindicatethatinfectionbyhigh-riskDNA-HPVisnotbyitselfenoughforthedevelopment ofcancerofthemouth.Itactsasacocarcinogen,adding itseffectstothemanyotherfactors,particularlysmoking andethylism.However,thesefindingsshowthatonethird ofthepatientswithcancerofthemouthhaveDNA-HPV tracesinthecancercells.
Even considering the importance of smoking and ethylism as the main factors in the pathogenesis of oral cancer, the identification of the HPV assumes a significantroleinthepreventionofthedisease,because itisnotsoeasytoestablishastheotherfactorsandits actualincidenceinthecurrentliteratureisstillnotwell determined.
Thelossoftheadenomatousgeneofpolyposiscoliand humaninfectionbytheHPVvirusinbuccalcarcinogenesis, highlightingthesynergicroleoftobaccoandalcoholas thechiefriskfactorsforthegenesisofcancerofthemouth hasbeenreportedand,inaddition,informationhasbeen produced on the association between buccal lesions involving the HPV virus and p-53 mutations, bearing in
References
4.CHEN,P.C.;KUO,C.;PAN,C.C.;CHOU,M.Y.Riskoforal cancerassociatedwithhumanpapillomavirusinfection,betel quidchewing,andcigarettesmokinginTaiwan:anintegrated molecularandepidemiologicalstudyof58cases.JOralPathol Med,v.31,n.6,p.317-22,2002.
5.DHARIWAL,S.K.;CUBIE,H.A.;SOUTHAN,J.C.Detection ofhumanpapillomavirusinorallesionsusingcommercially developedtypingkits.OralMicrobiolImmunol,v.10,p.60-3, 1995.
1.ARMSTRONG, B.Chemoprevention,WHO/OMS. 2001(http:
//www.who.int).
2. ATULA, S.; AUVINEN, E.; GRENMAN, R; SYRJANEN, S. HumanpapillomavirusandEpstein-Barrvirusinepithelial
carcinomas of the head and neck region.Anticancer Res,
v.17(6D),p.4427-33,1997.
3.BOLWEBSOLUÇÕESINTERNET.HPV–2001SociedadeBra-sileiradeInformaçõesdePatologiasUrológicas.Availableat: <http://www.uronews.org.br>.
Considering the finding of an absence of DNA-HPV (Tables1and2)theauthorsbelievethattheabsenceof DNA-HPVforthetypesstudiedin29samplesrepresenting 72.5%ofthematerialanalyzedbyhybridcapturetubetest
(Digene®technology)isactuallyduenotonlytotheabsence
of the virus in some cases, but also to ten cytological collections that were clinically classed as unsatisfactory, butsentforanalysisnonetheless.
Asregardstheanatomicalsiteinthebuccalcavity,of the29lesionsclassifiedwithanabsenceofDNA-HPVfor thetypesstudied,12ofthesquamouscellcarcinomaswere situated on the lower lip, 11 on the lateral edge of the tongue,fouronthefloorofthemouth,oneonthejugal mucusandoneonthesoftpalate.
The anatomical site of occurrence of the lesions observedanddiagnosedassquamouscellcarcinomaswas, indecreasingorder,asfollows:lateraledgeofthetongue, lowerlip,floorofthemouth,retromolartrigoneregion, jugalmucusandsoftpalate.
Thefindingsdemonstratethepresenceofthelow-andhigh-riskDNA-HPVvirusbythehybridcapturetubetest(Digene®
technology)inmoderatelyandwelldifferentiatedsquamouscell carcinomasoftheoralcavity,situatedmainlyonthelateraledge
ofthetongueandlowerlip;however,Zeuss,MillerandWhite(22)
reporttheidentificationoftheHPVvirusonlyinbenignlesions oftheoralcavity,suchascondylomaacuminatumandverruca vulgaris,butnotatallinpremalignantand/ormalignantlesions,
whileAtulaetal.(2);Dhariwal,CubieandSouthan(5);Lübbe
etal.(11)andMaoetal.(12)alsoidentifiedHPVs6and11(low
risk)associatedwithmalignanttumorsofthetonsilsinamuch greaterfrequencythanisusuallyobserved.
FurtherstudiesandresearchonthedetectionoftheHPV virus in the buccal mucosa and its possible carcinogenic action are required, bearing in mind that it is present in
over90%ofallinvasivecervicalcarcinomasofthewomb(7).
Prophylacticandtherapeuticvaccinesarebeingdeveloped
againstHPV,likethevaccinesagainstHelicobacterpylori,
whichispresentinpersonssufferingfromcancerofthe stomach,whichwilladdtotheexistingvaccinesagainst thehepatitisBandCvirusespresentincanceroftheliver. Thesevirusesrepresent90%ofalltheinfectionsassociated
withcancersinthedevelopedcountries(1,15).
Theresultsofthispilotstudynotonlyidentifiedthe presenceorabsenceofDNA-HPVforthevirusesofthe threegroups,A,B,andAandB,butalsoattesttothe validityofexfoliativecytologyasamethodabletoprovide suitableandsufficientmaterialfortheHybridCaptureTube
Test®,similarlytotheidentificationofthevirusinmaterial
obtainedbyexfoliativecytologyfromtheuterus.Inaddition, theyrevealthatthepropertiesoftheDigenetechnology enableittoidentifyHPVinoralneoplasms.
ItisthusconcludedthattheHPVvirusmaybehaveas onemorecocarcinogenforcancerofthemouth,alongside smoking,ethylism,andtheexposuretothesun,identified
in our sample. Chenet al.(4) showed that HPV 16 and
betel quid chewing were two major risk factors for oral squamouscellcarcinomaintheirstudies.Weare,however, continuingwiththepresentresearchsothatwewillbeable toextrapolatetheconclusionsdrawnfromthefindingsof thisinitialstudy.
Acknowledgements
Mailingaddress
AuroraKarladeLacerdaVidal
RuaJoãoEugêniodeLima67/702–BoaViagem CEP51030-360–Recife-PE
Tel.:(+55)(81)3462-8178/9977-5529 e-mails:[email protected] [email protected]
6.DIGENE.DiagnosticsInc.SãoPaulo,1999.
7. IARC. Monographs on the evaluation of carcinogenic risk to
humans.Humanpapillomaviruses,v.64,1995;viii+409p.
Availableat:<http://www.who.int>.
8. JONES,A. C.; PINK, F. E.; SANDOW, P. L.; STEWART, C. M.; MIGLIORATI, C.A.; BAUGHMAN, R.A.The cytobrush pluscellcollectorinoralcytology.OralSurgOralMedOral Pathol,v.77,p.101-4,1994.
9. KOSS, L. G. Diagnostic cytology and its histopathologic bases.3rded.JBLippincottCo.,1979.
10. LEVINE, A. M. Epidemiology and clinical aspects of human papillomavirus: associated diseases. Program and
Abstractof5thInternationalAidsMalignancyConference;
April23-25,2001;Bethesda,Maryland.
11.LÜBBE,J.etal.HPV-11andHPV-16:Associatedoralverrucous carcinoma.Dermatology,v.192,p.217-21,1996.
12. MAO, E-J.; SCHWARTZ, S. M.; DALING, J. R.; ODA, D.; TICKMAN, L.; BECKMANN, A. M. Human papilloma viruses and p53 mutations in normal, pre-malignant and malignantoralepithelia.PredOncol,v.69,p.152-258,1996. 13. MILLER, C. S.; JOHNSTONE, B. M. Human papillomavirus
as a risk factor for oral squamous cell carcinoma: a
meta-analysis, 1982-1997.Oral Surg Oral Med Oral Pathol
OralRadiolEndod,v.91,p.622-35,2001.
14.MINISTÉRIODASAÚDE.OproblemadocâncernoBrasil.4. ed.rev.eatual.RiodeJaneiro:INCa/Pró-Onco,1997.
15. MUÑOZ, N. Prevention of cancers associated with in-fectious agents.WHO/OMS 2001.Available at: <http: //www.who.int>.
16.ROBBINS,S.L.;COTRAN,R.S.;KUMAR,V.Patologiaestruturale
funcional.4.ed.RiodeJaneiro:GuanabaraKoogan,1991. 17. ROSAI, J.Ackerman’s surgical pathologies. Cap. 5: Oral cavity
andoralpharynx.7thed.St.Louis,Missoury:MosbyYear
BookInc.,1996.
18.SCHIFFMAN,H.etal.Accuracyandinterlaboratoryreliability ofhumanpapillomavirusDNAtestingbyhybridcapture. JournalofClinicalMicrobiology,p.545-50,1995.
19. SUGERMAN, P. B.; SAVAGE, N.W. Exfoliative cytology in clinicaloralpathology.AustralianDentalJournal,v.41,n.2, p.71-4,1996.
20.TAROMARU, E.; GALLO, C.; DÔRES, G. B. Captura híbrida.
A nova metodologia em biologia molecular. O Biócito.
Anatomia patológica, citopatologia, patologia clínica e ultra-sonografia,n.15,AnoIX,1998.
21.TURAZZA, E. et al. Low-risk human papillomavirus types 6 and 11 associated with carcinomas of genital and upper aero-digestive tract.Acta Obstet Gynecol Scand, v. 76, p. 271-6,1997.
22. ZEUSS, M. S.; MILLER, C . S.; WHITE, D. K.In situ